Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a classic "Black Swan" crisis management scenario. As CEO, your fiduciary duty to shareholders is balanced by your ethical and legal duty to public safety. In the pharmaceutical industry, the loss of trust is terminal.Read the full answer
I would not wait six months for more data. A potentially fatal signal affecting a drug used by millions requires immediate safety assessment, prompt engagement with regulators, and a plan to inform patients and clinicians.Read the full answer